$BCLI
BRAINSTORM CELL THERAPEUTICS INC.

2010 Form 10-K Financial Statement

#000114420412015305 Filed on March 15, 2012

View on sec.gov

Income Statement

Concept 2010
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.540M
YoY Change -1.91%
% of Gross Profit
Research & Development $1.050M
YoY Change 483.33%
% of Gross Profit
Depreciation & Amortization $160.0K
YoY Change -5.88%
% of Gross Profit
Operating Expenses $2.590M
YoY Change 48.0%
Operating Profit
YoY Change
Interest Expense $189.0K
YoY Change
% of Operating Profit
Other Income/Expense, Net $190.0K
YoY Change -733.33%
Pretax Income -$2.400M
YoY Change 34.83%
Income Tax $20.00K
% Of Pretax Income
Net Earnings -$2.419M
YoY Change 35.82%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$407.4K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2010
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.00K
YoY Change
Cash & Equivalents $90.00K
Short-Term Investments
Other Short-Term Assets $60.00K
YoY Change -14.29%
Inventory
Prepaid Expenses
Receivables $430.0K
Other Receivables $0.00
Total Short-Term Assets $580.0K
YoY Change 544.44%
LONG-TERM ASSETS
Property, Plant & Equipment $420.0K
YoY Change -27.59%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $90.00K
YoY Change 0.0%
Total Long-Term Assets $510.0K
YoY Change -23.88%
TOTAL ASSETS
Total Short-Term Assets $580.0K
Total Long-Term Assets $510.0K
Total Assets $1.090M
YoY Change 43.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $310.0K
YoY Change -48.33%
Accrued Expenses $510.0K
YoY Change -48.48%
Deferred Revenue
YoY Change
Short-Term Debt $140.0K
YoY Change -62.16%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.420M
YoY Change -40.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $130.0K
YoY Change 18.18%
Total Long-Term Liabilities $130.0K
YoY Change 18.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.420M
Total Long-Term Liabilities $130.0K
Total Liabilities $1.550M
YoY Change -38.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$460.0K
YoY Change
Total Liabilities & Shareholders Equity $1.090M
YoY Change 43.42%

Cashflow Statement

Concept 2010
OPERATING ACTIVITIES
Net Income -$2.419M
YoY Change 35.82%
Depreciation, Depletion And Amortization $160.0K
YoY Change -5.88%
Cash From Operating Activities -$2.070M
YoY Change 179.73%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $10.00K
YoY Change -75.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.160M
YoY Change 208.57%
NET CHANGE
Cash From Operating Activities -2.070M
Cash From Investing Activities 0.000
Cash From Financing Activities 2.160M
Net Change In Cash 90.00K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.070M
Capital Expenditures -$10.00K
Free Cash Flow -$2.060M
YoY Change 178.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
451000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1864000 USD
us-gaap Increase Decrease In Fair Value Of Unhedged Derivative Instruments
IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments
795000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-77000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
43914000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
164000 USD
us-gaap Net Income Loss
NetIncomeLoss
-44078000 USD
us-gaap Severance Costs
SeveranceCosts
12000 USD
CY2010 us-gaap Interest Expense
InterestExpense
189000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
24419000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17003000 USD
us-gaap Operating Expenses
OperatingExpenses
41422000 USD
us-gaap Interest Expense
InterestExpense
-2547000 USD
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
-132000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
43837000 USD
bcli Expenses Related To Shares And Options Granted To Service Providers
ExpensesRelatedToSharesAndOptionsGrantedToServiceProviders
21486000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
6821000 USD
bcli Increase In Accounts Receivable And Prepaid Expenses
IncreaseInAccountsReceivableAndPrepaidExpenses
381000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
717000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1397000 USD
bcli Erosion Of Restricted Cash
ErosionOfRestrictedCash
6000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-11347000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-23000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11370000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1133000 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-6000 USD
bcli Investment In Lease Deposit
InvestmentInLeaseDeposit
-17000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1144000 USD
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
-16000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1160000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12319000 USD
us-gaap Proceeds From Issuance Of Long Term Debt And Capital Securities Net
ProceedsFromIssuanceOfLongTermDebtAndCapitalSecuritiesNet
2061000 USD
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 USD
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
631000 USD
us-gaap Repayments Of Other Short Term Debt
RepaymentsOfOtherShortTermDebt
601000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
14410000 USD
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
43000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14453000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1923000 USD
bcli Conversion Of Trade Payable To Common Stock
ConversionOfTradePayableToCommonStock
0 USD
bcli Conversion Of Other Accounts Payable To Common Stock
ConversionOfOtherAccountsPayableToCommonStock
0 USD
bcli Conversion Of Convertible Note
ConversionOfConvertibleNote
0 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
1001000 USD

Files In Submission

Name View Source Status
0001144204-12-015305-index-headers.html Edgar Link pending
0001144204-12-015305-index.html Edgar Link pending
0001144204-12-015305.txt Edgar Link pending
0001144204-12-015305-xbrl.zip Edgar Link pending
bcli-20111231.xml Edgar Link completed
bcli-20111231.xsd Edgar Link pending
bcli-20111231_cal.xml Edgar Link unprocessable
bcli-20111231_def.xml Edgar Link unprocessable
bcli-20111231_lab.xml Edgar Link unprocessable
bcli-20111231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
image_001.jpg Edgar Link pending
image_004.jpg Edgar Link pending
logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v303574_10k.htm Edgar Link pending
v303574_ex23-1.htm Edgar Link pending
v303574_ex23-2.htm Edgar Link pending
v303574_ex31-1.htm Edgar Link pending
v303574_ex31-2.htm Edgar Link pending
v303574_ex32-1.htm Edgar Link pending
v303574_ex32-2.htm Edgar Link pending